Who We Are
Harnessing AI to revolutionise personalised medicine
CureLogic is a groundbreaking med-tech company harnessing the power of advanced AI to revolutionise personalised medicine. Our proprietary technology rapidly develops targeted microRNA treatments, delivering fast and reliable solutions for critical health conditions.
Focusing on heart disease and cancer — two of the deadliest global health threats — we create personalised therapies designed for maximum accuracy and effectiveness for each individual patient. We’re committed to improving healthcare with innovative, customised treatments.
Precision medicine as the new standard of care
We are a cross-disciplinary team of healthcare professionals, AI researchers, clinical data scientists, and technologists united by a single mission — to make precision medicine the new standard of care. We believe in a future where every patient receives care as unique as their DNA.
By leveraging cutting-edge AI, big data, and clinical insight, we turn complex medical information into actionable strategies — delivering precision-driven, personalised, and accessible healthcare, and bridging the gap between advanced research and real-world care.
What sets our platform apart
- A new AI-driven method to generate fine-tuned miRNA using state-of-the-art AI software.
- A new AI-powered alignment module to incorporate the patient’s transcriptomics, proteomics and metabolomics.
- A fully integrated high-throughput CRISPR platform for validation.
- Very short turnaround time through dedicated soft robotics.
- Fully integrated AI-CRISPR-Imaging platform for ultrafast and validated therapeutics.
- Dedicated soft robotics for rapid turnaround times.
- Personalised medicine is an upcoming market built on the new big-data era.
- Current therapeutics aren’t sufficiently tuned to the new personalised concepts.
- CureLogic offers a one-step approach to close this gap.
Pre-money valuation
IP assessed value
Funding required
Equity
Closing the gap in precision medicine
Standardised dosing isn't enough
Dosages are standardised by weight, surface area and gender — not pharmacodynamics or disease progression.
Disease progression depends on genetic, genomic, proteomic and environmental factors, each needing different therapeutics.
The current drug arsenal (~8,000–20,000 APIs) can’t treat the ~35,000 known diseases, let alone their progression levels (~100,000).
Bio-inspired microRNA at scale
We work with bio-inspired microRNA to tackle cellular complexity.
We modify microRNA (sy-miRNA) to create a repository of ~55M microRNA.
Combinations of sy-miRNA tune disease severity — expanding to ~200M new compounds.
Tissue-specific microRNA therapeutics increase dosage accuracy and reduce side effects.
One integrated, end-to-end platform
CureLogic has developed an integrated platform that couples our AI engine with an automatic strategy to align patient omics. A high-throughput CRISPR platform validates the proposed drugs on the patient’s own cells, with a dedicated robotic system delivering a 2–3 week turnover.
Precision diagnostics platform
Advanced AI-powered diagnostics using genetic, genomic, and proteomic profiles to tailor patient-specific treatment plans.
Custom drug manufacturing
On-demand manufacturing of personalised therapeutics driven by real-time diagnostic insights.
Innovative drug discovery
Integrating molecular research, AI models, and deep datasets to develop next-generation therapies.
Eliminating guesswork in healthcare
To make precision medicine accessible, affordable, and effective for every individual. By merging AI with real-time clinical and genetic data, we empower clinicians with tools that deliver accurate, efficient, and patient-specific insights — when and where it matters most.
We focus on:
Delivering personalised care solutions powered by AI.
Accelerating diagnoses and treatment accuracy.
Supporting doctors with intelligent clinical decision tools.
Manufacturing microRNA personalised signature drug treatment for each individual patient.
A world where care is tailored to the individual, not just the illness
To lead the global transition toward AI-empowered, personalised healthcare — where every medical decision is enhanced by intelligent data, early detection is standard, and technology empowers human expertise. Every solution we create is clinically validated, explainable, and designed with patients and practitioners at the centre.
Advanced technologies, one integrated platform
Our integrated platform brings together several advanced technologies to revolutionise therapeutic development.
AI-powered miRNA therapeutics
Using state-of-the-art AI algorithms, we generate personalised miRNA molecules designed to normalise disease-specific molecular signatures.
Soft robotic-powered high-throughput validation
Our novel platform can perform up to 100 compound studies per week, validating new therapeutics within just three weeks.
Comprehensive molecular profiling
We incorporate transcriptomics, proteomics, and metabolomics data to tailor treatments to each patient’s disease biology.
CRISPR integration & robotic synthesis
These cutting-edge tools allow rapid synthesis and precise validation of therapeutic compounds.
Fast turnaround times
Our robotic systems move therapies quickly from design to validation — delivering treatments when patients need them most.
We're here to support you
Reach out during the hours listed below — at your convenience.
Monday – Thursday
10:00 – 14:00
Friday
12:00 – 15:00
Saturday
13:00 – 15:00
Sunday
10:00 – 14:00
Let's talk
Take a look inside our laboratories
Our AI genomic research laboratories integrate advanced artificial intelligence with cutting-edge genomics to accelerate discoveries. We deploy automated pipelines for genome and exome sequencing, turning raw data into actionable biological and clinical insights, and collaborate with leading academic and industry partners to keep our research at the cutting edge of precision medicine.
Our journey is just beginning
While others build tech for labs, we build solutions for life — a world where diagnostics are faster, treatment is personalised, and care feels truly caring. We’re ready for what’s next, and we’re building it.